Page 64 - Retail Pharmacy November/Decemeber 2020

Scan to watch a wheezo demonstration The easy-to-use, hand held device measures breathing for 30 seconds Share accurate information with GPs and other health professionals Designed to assist with asthma management Document symptoms, episodes and medication use for asthma reviews Stockist enquiries: 0427510801 Visit: wheezo.com RRP: $99.50 wheezo is entered in the ARTG, 327306, with CE mark ®wheezo is a registered trademark of Respiri Limited. TMwheezo is a trademark of Respiri Limited. Respiri Limited, ACN – 009 234 173, Level 9, 432 St Kilda Road, Melbourne, VIC 3004. Ph: 1300 11 RESP (1300 11 7377). Date of preparation: November 2020. RESP128. CIPLA AUSTRALIA PTY. LTD. ABN: 46 132 155 063 | Registered office: Level 1, 132-136 Albert Road, South Melbourne, Vic-3205, Australia Contact: 03 9696 4413 | Fax: 03 9696 4662 People with asthma should consult their healthcare professional about their medical condition, their medications and the information collected within the wheezo eHealth app as part of their overall asthma management. Regardless of the wheeze rate, if the user has signs and symptoms such as chest tightness, shortness of breath, coughing or wheezing, they should always follow their healthcare professional’s advice and their asthma action plan